Correlation Between Coya Therapeutics, and Anixa Biosciences

Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Anixa Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Anixa Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Coya Therapeutics, Common and Anixa Biosciences, you can compare the effects of market volatilities on Coya Therapeutics, and Anixa Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Anixa Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Anixa Biosciences.

Diversification Opportunities for Coya Therapeutics, and Anixa Biosciences

0.47

Correlation Coefficient

Coya Therapeutics,  Anixa Biosciences

Very weak diversification

The 3 months correlation between Coya and Anixa is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Anixa Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anixa Biosciences and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Anixa Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anixa Biosciences has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Anixa Biosciences go up and down completely randomly.

Pair Corralation between Coya Therapeutics, and Anixa Biosciences

Given the investment horizon of 90 days Coya Therapeutics, Common is expected to generate 1.09 times more return on investment than Anixa Biosciences. However, Coya Therapeutics, is 1.09 times more volatile than Anixa Biosciences. It trades about -0.08 of its potential returns per unit of risk. Anixa Biosciences is currently generating about -0.3 per unit of risk. If you would invest  635.00  in Coya Therapeutics, Common on October 1, 2024 and sell it today you would lose (43.00) from holding Coya Therapeutics, Common or give up 6.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Coya Therapeutics, Common  vs.  Anixa Biosciences

Coya Therapeutics, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Coya Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Coya Therapeutics, is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Anixa Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anixa Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Coya Therapeutics, and Anixa Biosciences

The main advantage of trading using opposite Coya Therapeutics, and Anixa Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Anixa Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anixa Biosciences will offset losses from the drop in Anixa Biosciences' long position.

The idea behind Coya Therapeutics, Common and Anixa Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.